Literature DB >> 23375513

Suicidality associated with antiepileptic drugs: implications for the treatment of neuropathic pain and fibromyalgia.

Anthony Pereira1, Michael J Gitlin, Robert A Gross, Kelly Posner, Robert H Dworkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23375513      PMCID： PMC4556238          DOI： 10.1016/j.pain.2012.12.024

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  7 in total

Review 1.  The risk of suicide mortality in chronic pain patients.

Authors:  Afton L Hassett; Jordan K Aquino; Mark A Ilgen
Journal:  Curr Pain Headache Rep       Date:  2014

2.  Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and the Underlying Mechanism.

Authors:  Ding Wang; Hua Yang; Yingying Liang; Xin Wang; Xiaolei Du; Runtao Li; Yimin Jiang; Jia Ye
Journal:  Neurochem Res       Date:  2019-11-06       Impact factor: 3.996

Review 3.  Pressure pain assessment may predict the outcome of spinal cord stimulation for refractory epilepsy.

Authors:  Li Feng; Li-Hua Fan; Duo-Zhi Wu
Journal:  Am J Clin Exp Immunol       Date:  2018-12-20

Review 4.  Pharmacological treatment of chronic non-cancer pain in pediatric patients.

Authors:  Eapen Mathew; Eugene Kim; Kenneth R Goldschneider
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

5.  Complex pain phenotypes: Suicidal ideation and attempt through latent multimorbidity.

Authors:  Kangwon Song; Ben J Brintz; Chen-Pin Wang; Donald D McGeary; Cindy A McGeary; Jennifer S Potter; Carlos A Jaramillo; Blessen C Eapen; Mary Jo Pugh
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.752

6.  Suicide Risk Management Protocol for a Randomized Controlled Trial of Cardiac Patients Reporting Hopelessness.

Authors:  Susan L Dunn; Holli A DeVon; Eileen G Collins; Anna Luong; Madison P Buursma; Melissa Gutierrez-Kapheim; Ulf G Bronas
Journal:  Nurs Res       Date:  2021 Jan/Feb       Impact factor: 2.381

7.  Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).

Authors:  E Besi; D R Boniface; R Cregg; J M Zakrzewska
Journal:  J Headache Pain       Date:  2015-09-03       Impact factor: 7.277
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.